- Messages
- 33
Is isosorbide mononitrate only available with prescription (doctor) in the U.K or is it listed as "pharmacy only" ?
http://webcache.googleusercontent.com/search?q=cache:tHR7z0WqKLMJ:www.mims.co.uk/drugs/cardiovascular-system/angina/imdur &cd=1&hl=en&ct=clnk&gl=no
Mims say it is "P- pharmacy-only medicine "A product that may only be sold in a registered pharmacy under the supervision of a registered pharmacist"
Pharmacies on the other hand claim that it is listed as prescription only:
http://www.clearchemist.co.uk/isosorbide-mononitrate-xl-tab-monosorb-60mg.html
While this http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con143652.pdf
says
What is correct here?
http://webcache.googleusercontent.com/search?q=cache:tHR7z0WqKLMJ:www.mims.co.uk/drugs/cardiovascular-system/angina/imdur &cd=1&hl=en&ct=clnk&gl=no
Mims say it is "P- pharmacy-only medicine "A product that may only be sold in a registered pharmacy under the supervision of a registered pharmacist"
Pharmacies on the other hand claim that it is listed as prescription only:
http://www.clearchemist.co.uk/isosorbide-mononitrate-xl-tab-monosorb-60mg.html
While this http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con143652.pdf
says
The MHRA granted Marketing Authorisations for the medicinal products Medomil 20mg and 40mg Tablets (PL 21880/0117-8) to Medreich PLC on 16th December 2011. These products are dispensed in pharmacies only and hence, have legal status (P). They are indicated for:
- the prophylaxis of angina pectoris
- adjunctive therapy in congestive heart failure not responding to cardiac glycosides or
diuretics.
These applications for Medomil 20mg and 40mg Tablets are submitted according to Article 10c of Directive 2001/83/EC as amended, cross-referring to Isosorbide Mononitrate 20mg and 40mg Tablets (PL 16363/0001-2), which were approved to Milpharm Limited on 28th May 2007 and 21st September 1998 respectively.
What is correct here?
Last edited: